We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
108 hedge funds and large institutions have $201M invested in Zevra Therapeutics in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 19 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
231% more call options, than puts
Call options by funds: $6.94M | Put options by funds: $2.1M
156% more capital invested
Capital invested by funds: $78.6M → $201M (+$122M)
125% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 12
100% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 19
16.7% more ownership
Funds ownership: 38.33% → 55.04% (+17%)
16% more funds holding
Funds holding: 93 → 108 (+15)
Holders
108
Holders Change
+15
Holders Change %
+16.13%
% of All Funds
1.55%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.04%
New
27
Increased
38
Reduced
19
Closed
12
Calls
$6.94M
Puts
$2.1M
Net Calls
+$4.84M
Net Calls Change
+$4.16M
Top Buyers
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$19.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.7M |
| 3 |
JGC
J. Goldman & Co
New York
|
+$6.68M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.26M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$4.75M |
